SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-177282
Filing Date
2015-05-07
Accepted
2015-05-07 16:48:33
Documents
4
Period of Report
2015-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d924867d8k.htm 8-K 29810
2 EX-10.1 d924867dex101.htm EX-10.1 78840
3 EX-99.1 d924867dex991.htm EX-99.1 9459
4 GRAPHIC g924867ex99_1pg01.jpg GRAPHIC 5108
  Complete submission text file 0001193125-15-177282.txt   126658
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 15842516
SIC: 8093 Services-Specialty Outpatient Facilities, NEC